טוען...
Neoadjuvant chemoradiotherapy for locally advanced rectal cancer: The debate continues
Rectal carcinoma represents the 30% of all colorectal cancers, with about 40000 new cases/years. In the past two decades, the management of rectal cancer has made important progress, highlighting the main role of a multimodality strategy approach, combining surgery, radiation therapy and chemotherap...
שמור ב:
| הוצא לאור ב: | World J Gastrointest Oncol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Baishideng Publishing Group Inc
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4266815/ https://ncbi.nlm.nih.gov/pubmed/25516776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v6.i12.438 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|